|
Volumn 48, Issue 12, 2009, Pages 1140-1142
|
Pharmacogenomics of Methylphenidate Response: Making Progress
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOPAMINE 4 RECEPTOR;
METHYLPHENIDATE;
SEROTONIN TRANSPORTER;
ALLELE;
ATTENTION DEFICIT DISORDER;
BIPOLAR DISORDER;
CHILD ABUSE;
CLINICAL DECISION MAKING;
EDITORIAL;
FAMILY HISTORY;
GENE FREQUENCY;
GENE SEQUENCE;
GENETIC ASSOCIATION;
GENETIC TRANSCRIPTION;
GENETIC VARIABILITY;
GENOTYPE;
HEALTH CARE COST;
HOMOZYGOSITY;
HUMAN;
INTRON;
MATHEMATICS;
MEDICAL RECORD;
MENTAL DISEASE;
PHARMACOGENOMICS;
PREDICTION;
PRIORITY JOURNAL;
PROBABILITY;
PROMOTER REGION;
SINGLE NUCLEOTIDE POLYMORPHISM;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
UPREGULATION;
VARIABLE NUMBER OF TANDEM REPEAT;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CENTRAL NERVOUS SYSTEM STIMULANTS;
FEMALE;
GENETIC ASSOCIATION STUDIES;
HUMANS;
MALE;
METHYLPHENIDATE;
PHARMACOGENETICS;
|
EID: 71649115235
PISSN: 08908567
EISSN: 15275418
Source Type: Journal
DOI: 10.1097/CHI.0b013e3181bfa91b Document Type: Editorial |
Times cited : (4)
|
References (3)
|